Abstract
Stereotactic ablative body radiotherapy (SABR) is the standard of care for patients with early-stage lung cancer who are unable to undergo surgery. Although SABR is generally well-tolerated, radiation-induced lung injury (RILI) can occur in up to 58% of treated patients, which can be difficult to distinguish from local recurrence in follow-up imaging. Predictive markers that identify patients at greater risk of RILI may aid in the interpretation of post-treatment imaging. In this retrospective study, we investigated whether dosimetric data correlate with the relative volume of post-treatment RILI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
